Scientists develop yearly HIV injection: How it could help millions
HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...
This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...
FMIBlog2d
Global HIV Antivirals Market Poised for Remarkable Growth, Projected to Reach USD 47.0 Billion by 2032 register a CAGR of 4.4%
The global HIV antivirals market is experiencing substantial growth, fueled by rising global awareness, advancements in pharmaceutical research, and the increasing adoption of innovative treatment ...
The American Journal of Managed Care10d
Global Status of HIV/AIDS Pandemic Takes Center Stage in Opening Session
The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...
Medscape1d
Twice Daily TB Therapies Show Similar Neuropsychiatric Outcomes in Patients with HIV
Previous research has suggested an increased risk for neuropsychiatric symptoms in people living with HIV who are being treated with INST (Integrase Strand Transfer) inhibitor antiretrovirals, Gillian ...
Houston Chronicle11d
From TB to HIV/AIDS to cancer, disease tracking has always had a political dimension, but it’s the foundation of public health
AIDS arrived as American politics took a sharp conservative turn with the election of President Ronald Reagan. When in 1985 it became possible to test for HIV, the virus that causes AIDS, the prospect ...